Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Future blockbusters 2013

Click to download the PDF to view the full issue An upswing in NME approvals is an encouraging sign for an industry trying to overcome mega-brand patent expirations and a lag in research and development productivity. R&D expenditure growth for the industry as a whole has reached a stagnant state, though many companies remain dedicated […]

Read More »

In The Twilight Zone 2013

Click to download the PDF to view the full issue The Caronia decision was excitedly hailed as a breakthrough for pharmaceutical marketing, but industry observers say as FDA continues business as usual, pharma companies are not changing their tactics – though the ruling could open the way for the industry to engage in online conversations. […]

Read More »

Best New Medicine 2013

Click to download the PDF to view the full issue Stopping The Bleeding Partner marketers Bristol-Myers Squibb and Pfizer are hoping to recover from major patent losses with the help of the Factor Xa inhibitor Eliquis, Med Ad News’ Best New Medicine of the Year. Christmas came a few days late in 2012 for two […]

Read More »

93 New Medicines 2013

Click to download the PDF to view the full issue New Medicines List (Excel Document) FDA regulators during 2012 approved 39 new molecular entities, the highest amount in one year since 1997. U.S. regulators last year approved for marketing 93 new medicines according to Med Ad News criteria. This figure represents an additional 13 products […]

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

October 2017 Focus: Manufacturer of the Year, Top 50 Pharma, HBA and more!

Subscribe

Ad Right Bottom

Main Navigation